EICAR (antiviral) (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "EICAR (antiviral)" in English language version.

refsWebsite

Global rank English rank

16nih.gov

4^th place

13doi.org

2^nd place

2semanticscholar.org

11^th place

8^th place

doi.org

Matsuda A, Minakawa N, Sasaki T, Ueda T (July 1988). "The design, synthesis and antileukemic activity of 5-alkynyl-1-beta-D-ribofuranosylimidazole-4-carboxamides". Chemical & Pharmaceutical Bulletin. 36 (7): 2730–2733. doi:10.1248/cpb.36.2730. PMID 3272143.
Minakawa N, Takeda T, Sasaki T, Matsuda A, Ueda T (February 1991). "Nucleosides and nucleotides. 96. Synthesis and antitumor activity of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives". Journal of Medicinal Chemistry. 34 (2): 778–786. doi:10.1021/jm00106a045. PMID 1995901.
De Clercq E, Cools M, Balzarini J, Snoeck R, Andrei G, Hosoya M, et al. (April 1991). "Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds". Antimicrobial Agents and Chemotherapy. 35 (4): 679–684. doi:10.1128/aac.35.4.679. PMC 245078. PMID 2069373.
Jashés M, González M, López-Lastra M, De Clercq E, Sandino A (March 1996). "Inhibitors of infectious pancreatic necrosis virus (IPNV) replication". Antiviral Research. 29 (2–3): 309–312. doi:10.1016/0166-3542(96)80226-9. PMID 8739609.
Dal Pozzo F, Galligioni V, Vaccari F, Gallina L, Battilani M, Scagliarini A (April 2010). "Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro". Research in Veterinary Science. 88 (2): 339–344. doi:10.1016/j.rvsc.2009.08.010. PMID 19781726.
Barnard DL, Day CW, Bailey K, Heiner M, Montgomery R, Lauridsen L, et al. (August 2006). "Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin". Antiviral Research. 71 (1): 53–63. doi:10.1016/j.antiviral.2006.03.001. PMC 7114261. PMID 16621037.
De Clercq E (2015). "Curious (Old and New) Antiviral Nucleoside Analogues with Intriguing Therapeutic Potential". Current Medicinal Chemistry. 22 (34): 3866–3880. doi:10.2174/0929867322666150625094705. PMID 26112146.
Okano Y, Saito-Tarashima N, Kurosawa M, Iwabu A, Ota M, Watanabe T, et al. (June 2019). "Synthesis and biological evaluation of novel imidazole nucleosides as potential anti-dengue virus agents". Bioorganic & Medicinal Chemistry. 27 (11): 2181–2186. doi:10.1016/j.bmc.2019.04.015. PMID 31003866. S2CID 124129370.
De Clercq E (November 2019). "New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections". Chemistry: An Asian Journal. 14 (22): 3962–3968. doi:10.1002/asia.201900841. PMC 7159701. PMID 31389664.
Balzarini J, Karlsson A, Wang L, Bohman C, Horská K, Votruba I, et al. (November 1993). "Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis". The Journal of Biological Chemistry. 268 (33): 24591–24598. doi:10.1016/S0021-9258(19)74507-4. PMID 7901217.
Qian X, Liu H, Xu D, Xu L, Huang F, He W, et al. (September 2017). "Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and Meta-analysis". The Aging Male. 20 (3): 184–191. doi:10.1080/13685538.2017.1295436. PMID 28368238. S2CID 25963580.
Jashés M, Mlynarz G, De Clercq E, Sandino AM (January 2000). "Inhibitory effects of EICAR on infectious pancreatic necrosis virus replication". Antiviral Research. 45 (1): 9–17. doi:10.1016/S0166-3542(99)00071-6. PMID 10774586.
Dal Pozzo F, Galligioni V, Vaccari F, Gallina L, Battilani M, Scagliarini A (April 2010). "Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro". Research in Veterinary Science. 88 (2): 339–344. doi:10.1016/j.rvsc.2009.08.010. PMID 19781726.

nih.gov

pubmed.ncbi.nlm.nih.gov

Matsuda A, Minakawa N, Sasaki T, Ueda T (July 1988). "The design, synthesis and antileukemic activity of 5-alkynyl-1-beta-D-ribofuranosylimidazole-4-carboxamides". Chemical & Pharmaceutical Bulletin. 36 (7): 2730–2733. doi:10.1248/cpb.36.2730. PMID 3272143.
Minakawa N, Takeda T, Sasaki T, Matsuda A, Ueda T (February 1991). "Nucleosides and nucleotides. 96. Synthesis and antitumor activity of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives". Journal of Medicinal Chemistry. 34 (2): 778–786. doi:10.1021/jm00106a045. PMID 1995901.
De Clercq E, Cools M, Balzarini J, Snoeck R, Andrei G, Hosoya M, et al. (April 1991). "Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds". Antimicrobial Agents and Chemotherapy. 35 (4): 679–684. doi:10.1128/aac.35.4.679. PMC 245078. PMID 2069373.
Jashés M, González M, López-Lastra M, De Clercq E, Sandino A (March 1996). "Inhibitors of infectious pancreatic necrosis virus (IPNV) replication". Antiviral Research. 29 (2–3): 309–312. doi:10.1016/0166-3542(96)80226-9. PMID 8739609.
Dal Pozzo F, Galligioni V, Vaccari F, Gallina L, Battilani M, Scagliarini A (April 2010). "Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro". Research in Veterinary Science. 88 (2): 339–344. doi:10.1016/j.rvsc.2009.08.010. PMID 19781726.
Barnard DL, Day CW, Bailey K, Heiner M, Montgomery R, Lauridsen L, et al. (August 2006). "Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin". Antiviral Research. 71 (1): 53–63. doi:10.1016/j.antiviral.2006.03.001. PMC 7114261. PMID 16621037.
De Clercq E (2015). "Curious (Old and New) Antiviral Nucleoside Analogues with Intriguing Therapeutic Potential". Current Medicinal Chemistry. 22 (34): 3866–3880. doi:10.2174/0929867322666150625094705. PMID 26112146.
Okano Y, Saito-Tarashima N, Kurosawa M, Iwabu A, Ota M, Watanabe T, et al. (June 2019). "Synthesis and biological evaluation of novel imidazole nucleosides as potential anti-dengue virus agents". Bioorganic & Medicinal Chemistry. 27 (11): 2181–2186. doi:10.1016/j.bmc.2019.04.015. PMID 31003866. S2CID 124129370.
De Clercq E (November 2019). "New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections". Chemistry: An Asian Journal. 14 (22): 3962–3968. doi:10.1002/asia.201900841. PMC 7159701. PMID 31389664.
Balzarini J, Karlsson A, Wang L, Bohman C, Horská K, Votruba I, et al. (November 1993). "Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis". The Journal of Biological Chemistry. 268 (33): 24591–24598. doi:10.1016/S0021-9258(19)74507-4. PMID 7901217.
Qian X, Liu H, Xu D, Xu L, Huang F, He W, et al. (September 2017). "Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and Meta-analysis". The Aging Male. 20 (3): 184–191. doi:10.1080/13685538.2017.1295436. PMID 28368238. S2CID 25963580.
Jashés M, Mlynarz G, De Clercq E, Sandino AM (January 2000). "Inhibitory effects of EICAR on infectious pancreatic necrosis virus replication". Antiviral Research. 45 (1): 9–17. doi:10.1016/S0166-3542(99)00071-6. PMID 10774586.
Dal Pozzo F, Galligioni V, Vaccari F, Gallina L, Battilani M, Scagliarini A (April 2010). "Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro". Research in Veterinary Science. 88 (2): 339–344. doi:10.1016/j.rvsc.2009.08.010. PMID 19781726.

ncbi.nlm.nih.gov

De Clercq E, Cools M, Balzarini J, Snoeck R, Andrei G, Hosoya M, et al. (April 1991). "Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds". Antimicrobial Agents and Chemotherapy. 35 (4): 679–684. doi:10.1128/aac.35.4.679. PMC 245078. PMID 2069373.
Barnard DL, Day CW, Bailey K, Heiner M, Montgomery R, Lauridsen L, et al. (August 2006). "Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin". Antiviral Research. 71 (1): 53–63. doi:10.1016/j.antiviral.2006.03.001. PMC 7114261. PMID 16621037.
De Clercq E (November 2019). "New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections". Chemistry: An Asian Journal. 14 (22): 3962–3968. doi:10.1002/asia.201900841. PMC 7159701. PMID 31389664.

semanticscholar.org

api.semanticscholar.org

Okano Y, Saito-Tarashima N, Kurosawa M, Iwabu A, Ota M, Watanabe T, et al. (June 2019). "Synthesis and biological evaluation of novel imidazole nucleosides as potential anti-dengue virus agents". Bioorganic & Medicinal Chemistry. 27 (11): 2181–2186. doi:10.1016/j.bmc.2019.04.015. PMID 31003866. S2CID 124129370.
Qian X, Liu H, Xu D, Xu L, Huang F, He W, et al. (September 2017). "Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and Meta-analysis". The Aging Male. 20 (3): 184–191. doi:10.1080/13685538.2017.1295436. PMID 28368238. S2CID 25963580.